ETFIQData as of Nov 18, 2026. · etfiq.com/funds/abls

ABLS Fact Sheet: Abacus FCF Small Cap Leaders ETF

Share
$22.07
close, Nov 18, 2026

Over the year to Nov 18, 2026, ABLS returned +11.5% in total and charged 0.39% a year.

1-year total return
+11.5%
IWM +16.9% to Nov 18, 2026
Expense ratio
0.39%
a year
Net flow, 12 months to Jul 31, 2026
−$698k
monthly N-PORT basis to Jul 31, 2026

Growth of $10,000, 1 year

ABLS $11,153 +11.5% · IWM $11,687 +16.9% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+4.2%
3 months−4.7%
Year to date+10.9%
1 year+11.5%
Since launch+1.3%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
Argan Inc11.79%
Enova International Inc6.46%
Oscar Health Inc5.83%
Artisan Partners Asset Managem4.38%
Collegium Pharmaceutical Inc4.27%
Healthcare Services Group Inc3.73%
Harmony Biosciences Holdings I3.58%
Qualys Inc3.40%
Kontoor Brands Inc3.39%
Progyny Inc3.32%

ABLS top ten by weight, 50.1% of the fund, of its 46 equity positions, from the holdings filed for Jul 31, 2026.

Facts

Equity fund · First traded Feb 19, 2025 · Benchmark Russell 2000 Total Return Index, measured by IWM, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, ABLS Fact Sheet: Abacus FCF Small Cap Leaders ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/abls/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/abls.